iFOB Test
HEMOSURE
Hemosure® is the latest advanced technological breakthrough in Immunological Fecal Occult Blood Testing (iFOBT), which is approved, by the Food and Drug Administration (FDA) and is also CLIA waived. We offer various kits that are configured to best suit your department needs. Our test is most cost effective test in the market today!
|
|
Hemosure® One Step Immunological Fecal Occult Blood Test is a qualitative, sandwich dye conjugate immunoassay and employs a unique combination of monoclonal and polyclonal antibodies to selectively identify hemoglobin in test samples with a high degree of sensitivity. In less than five minutes, elevated levels of human hemoglobin (hHb) as low as 50ng hHb/mL can be detected and positive results for high levels of hemoglobin can be seen in the test as early as two to three minutes. As the test sample flows up through the absorbent device, the labeled antibody-dye conjugate binds to the hemoglobin in the specimen forming an antibody-antigen complex. This complex binds to antihemoglobin antibody in the positive test reaction zone and produces a pink-rose color band. In the absence of hemoglobin, there is no line in the positive test reaction zone. The pink-rose color bands in the control reaction zone demonstrate that the reagents and devices are functioning correctly.
HEMOSURE
5358 Irwindale Ave. | | Irwindale | CA |
Hemosure, Inc. is a privately held corporation headquartered at El Monte, California, only 15 minutes away from downtown Los Angeles. The Company is a pioneer in the research and development of one-step rapid membrane tests. It has been designated a registered GMP facility for in vitro diagnostic medical devices by the FDA.
|
|
iFOBT
POLYMEDCO, INC.
iFOBT
|
|
The Clearview® ULTRA FOB Test is a manual immunoassay for the rapid detection of human hemoglobin in feces.
POLYMEDCO, INC.
510 Furnace Dock Road | | Cortlandt Manor | NY |
Polymedco Inc. is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and devices that are specialized in chemistry, hematology and cancer.
|
|
Hemoccult® II Sensa
BECKMAN COULTER, INC.
Hemoccult® SENSA fecal occult blood tests have been used with confidence in medical practice as a way to enhance detection of hidden blood in stool specimens, an early indication of colorectal cancer. Many recent studies show that annual screening with Hemoccult¨ will reduce mortality from colorectal cancer by 20 to 40 percent.
|
|
The Hemoccult II SENSA test is a rapid, convenient and qualitative method for detecting fecal occult blood which may be
indicative of gastrointestinal disease. It is not a test for colorectal cancer or any other specific disease. Hemoccult II SENSA is the enhanced
Hemoccult product that provides improved readability and higher clinical sensitivity over regular Hemoccult and other FOBTs. Hemoccult II SENSA has
been proven to give the highest clinical sensitivity readings (92%) and offers the ability to find more true positives of occult blood. Since polyps and cancer may
bleed intermittently, Hemoccult II SENSA triple slide products are designed so patients can collect serial specimens over 3 days, increasing the
probability of detecting hidden blood from polyps and cancer.
BECKMAN COULTER, INC.
200 South Kraemer Blvd. M/S M-362 | PO Box 8000 | Brea | CA |
Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing.
|
|
Hemoccult® Fecal Occult Blood Test
BECKMAN COULTER, INC.
For thirty years, the Hemoccult® fecal occult blood test (FOBT) has been aiding physicians in detecting hidden blood in stool specimens as an early indication of colorectal cancer. More than 300 studies using Hemoccult¨ products many of which were conducted over long periods of time with large numbers of participants- have been published in leading medical journals around the world. As a result of these studies, the American Cancer Society and other healthcare and medical agencies now recommend
|
|
Hemoccult is the #1 brand in FOBTs.
Used with confidence by physicians for over 40 years, Hemoccult brand products are supported in over 300 clinical publications The American Cancer Society recommends the use of high-sensitivity guaiac-based FOBTs (such as Hemoccult SENSA) or fecal immunochemical tests (FIT) as an effective screening method for CRC. Rigorous prequalification of raw materials and a unique quality control system yields a high degree of lot- to-lot consistency. Hemoccult products are used and trusted by top American medical institutions and healthcare professionals and millions of people have been screened with Hemoccult products, resulting in many lives saved.
BECKMAN COULTER, INC.
200 South Kraemer Blvd. M/S M-362 | PO Box 8000 | Brea | CA |
Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing.
|